Anfarm Hellas S.A. - Main Component
Active Substance | Strength | Form |
---|---|---|
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In |
Active Substance | Strength | Form |
---|---|---|
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In |
Active Substance | Strength | Form | Market Availability |
---|---|---|---|
RemifentanilUnder Development | 1, 2 and 5 mg/vial | Pd.C.So.In | Q2 2024 |